NASDAQ:INKT | Profit Breakdown | MiNK Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$3.22M-$3.13M
2026-03-31-$2.88M-$2.74M
2025-12-31-$2.71M-$2.6M
2025-09-30-$3.18M-$2.89M
2025-06-30-$4.05M-$4.24M
2025-03-31-$2.7M-$2.77M
2024-12-31-$2.5M-$2.46M
2024-09-30-$1.88M-$1.81M
2024-06-30-$3.07M-$2.7M
2024-03-31-$3.83M-$3.81M
2023-12-31-$5.5M-$5.46M
2023-09-30-$5.22M-$5.12M
2023-06-30-$6.34M-$6.2M
2023-03-31-$5.85M-$5.69M
2022-12-31-$7.89M-$7.77M
2022-09-30-$7.99M-$6.33M
2022-06-30-$7.7M-$6.11M
2022-03-31-$7.37M-$7.78M
2021-12-31-$6.36M-$5.76M
2021-09-30-$13.38M-$14.27M
2021-06-30-$5.61M-$6.34M
2021-03-31-$3.01M-$3.85M
2020-12-31-$1.52M-$1.54M
2020-09-30-$5.92M-$6.04M
2020-06-30-$4.27M
2020-03-31-$4.39M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$12.64M-$12.49M
2024-12-31-$11.29M-$10.78M
2023-12-31-$22.92M-$22.46M
2022-12-31-$30.95M-$27.99M
2021-12-31-$28.36M-$30.21M
2020-12-31-$14.64M-$16.24M